Get Your Personalized Supplement StackSupplement Stack Quiz

Kava Kava Rhizome And Root Concentrate

Also known as: Kava, Kava Kava, Piper methysticum

Overview

Kava Kava, scientifically known as Piper methysticum, is a traditional South Pacific plant primarily recognized for its rhizome and root extracts. These extracts contain active compounds called kavalactones, which are responsible for its anxiolytic (anxiety-reducing) and sedative properties. Available as a herbal supplement, kava is used to alleviate anxiety and promote relaxation. Research on kava's efficacy and safety is extensive, with numerous randomized controlled trials, systematic reviews, and meta-analyses supporting its use for anxiety disorders. However, its application is complicated by well-documented safety concerns, particularly regarding potential hepatotoxicity, which has led to regulatory restrictions in various regions. The supplement is available in different extract forms, including water-based and ethanol concentrates, with the traditional water-based preparations generally considered safer.

Benefits

Kava rhizome and root extracts have demonstrated significant anxiolytic effects in clinical trials, particularly for generalized anxiety disorder (GAD) and subclinical anxiety. A meta-analysis of seven randomized controlled trials (RCTs) showed a substantial reduction in anxiety symptoms, as measured by the Hamilton Anxiety Scale (HAMA), compared to placebo, indicating strong clinical relevance. While its primary benefit is anxiety reduction, some evidence suggests kava may also help alleviate tension and restlessness due to its mild sedative properties. Benefits typically manifest within 4-6 weeks of consistent use. However, evidence for other uses, such as sleep improvement or benzodiazepine withdrawal, remains limited or inconclusive. Caution is advised for patients with pre-existing liver conditions or those concurrently taking other psychotropic medications.

How it works

Kava's anxiolytic effects are primarily mediated through its modulation of the GABAergic system in the brain. This includes altering lipid membrane structure and influencing sodium channel function. Additionally, kava inhibits monoamine oxidase B and the reuptake of noradrenaline and dopamine, contributing to its psychotropic effects. Kavalactones are the main bioactive constituents responsible for these actions. The method of extraction significantly influences the concentration and bioavailability of these kavalactones. Traditional water-based extracts are generally considered safer and effective, while ethanol extracts yield higher kavalactone concentrations but may carry an increased risk of adverse effects.

Side effects

Kava is generally well-tolerated for short-term use at recommended doses, but rare yet serious cases of hepatotoxicity, including hepatitis and liver failure, have been reported, leading to regulatory restrictions in some countries. Common side effects, affecting more than 5% of users, include mild gastrointestinal discomfort, headache, dizziness, and drowsiness. Uncommon side effects (1-5%) may include allergic reactions, skin rash, and mild neurological symptoms. The severe liver injury cases are mostly linked to high doses, long-term use, or non-traditional extracts. Kava has potential interactions with other central nervous system depressants, alcohol, and hepatotoxic drugs, necessitating caution when combined with psychotropic medications. It is contraindicated in individuals with pre-existing liver disease, during pregnancy and lactation, and for children under 12 years. Routine liver function monitoring is recommended for regular users.

Dosage

The minimum effective dose of kava extracts standardized to kavalactones is typically 40 mg per dose. The optimal daily dosage generally ranges from 120-240 mg of kavalactones, usually divided into two or three doses throughout the day. A definitive maximum safe dose has not been established, and it is crucial not to exceed recommended dosages due to the risk of hepatotoxicity. Due to its sedative effects, kava should not be used before driving or operating heavy machinery. Traditional water-based extracts are preferred for safety, although ethanol extracts contain higher kavalactone concentrations. Food intake may influence absorption, and standardized extracts help ensure consistent dosing. No specific cofactors are required for its efficacy.

FAQs

Is kava safe for long-term use?

Long-term safety is uncertain; the risk of liver toxicity increases with prolonged use and higher doses, so it's generally not recommended for extended periods.

Can kava be used with alcohol?

No, concurrent use of kava and alcohol is strongly discouraged as it significantly increases the risk of central nervous system depression and liver damage.

How quickly does kava work?

Anxiolytic effects typically become noticeable within 2 to 6 weeks of consistent, regular use, rather than providing immediate relief.

Does kava cause addiction?

There is no strong evidence to suggest that kava has addictive potential, though tolerance and dependence have not been extensively studied.

Is kava effective for all anxiety types?

Evidence primarily supports kava's efficacy for generalized anxiety disorder; its effectiveness for other anxiety types is less clear and requires more research.

Research Sources

https://www.ema.europa.eu/en/documents/herbal-report/draft-assessment-report-piper-methysticum-g-forst-rhizoma_en.pdf – This EMA assessment report, based on over 1700 publications, confirms the anxiolytic efficacy of kava rhizome extracts standardized to kavalactones. It details extraction methods, dosing, and safety profiles, including the significant risk of hepatotoxicity. The report recommends restricted use with liver monitoring and avoidance in vulnerable populations, providing a comprehensive regulatory perspective on kava's use.
https://journals.sagepub.com/doi/10.3109/00048674.2010.522554 – This comprehensive review by Sarris et al. (2010) analyzed clinical trials and pharmacology of kava, confirming its anxiolytic efficacy with a mean effect size of 1.1 on the HAMA scale. The authors emphasize the importance of using traditional water extracts and monitoring liver function. They also highlight the ongoing need for further randomized controlled trials comparing kava to conventional anxiolytics.
https://pubmed.ncbi.nlm.nih.gov/10653213/ – The systematic review and meta-analysis by Pittler et al. (2000) included multiple randomized controlled trials, demonstrating that kava extract significantly reduced anxiety symptoms compared to placebo. Despite good methodological quality, limitations included heterogeneity in extract types and doses. The study concluded kava's effectiveness for anxiety but advised caution due to safety concerns, particularly regarding liver toxicity.